...
首页> 外文期刊>Science China Life Sciences >Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells
【24h】

Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells

机译:基于最小S / MAR序列的非整合慢病毒载体保留分割细胞中的转基因表达

获取原文
           

摘要

Safe and efficient gene transfer systems are the basis of gene therapy applications. Non-integrating lentiviral (NIL) vectors are among the most promising candidates for gene transfer tools, because they exhibit high transfer efficiency in both dividing and non-dividing cells and do not present a risk of insertional mutagenesis. However, non-integrating lentiviral vectors cannot introduce stable exogenous gene expression to dividing cells, thereby limiting their application. Here, we report the design of a non-integrating lentiviral vector that contains the minimal scaffold/matrix attachment region (S/MAR) sequence (SNIL), and this SNIL vector is able to retain episomal transgene expression in dividing cells. Using SNIL vectors, we detected the expression of the eGFP gene for 61 days in SNIL-transduced stable CHO cells, either with selection or not. In the NIL group without the S/MAR sequence, however, the transduced cells died under selection for the transient expression of NIL vectors. Furthermore, Southern blot assays demonstrated that the SNIL vectors were retained extrachromosomally in the CHO cells. In conclusion, the minimal S/MAR sequence retained the non-integrating lentiviral vectors in dividing cells, which indicates that SNIL vectors have the potential for use as a gene transfer tool.
机译:安全高效的基因转移系统是基因治疗应用的基础。非整合慢病毒(NIL)载体是基因转移工具最有希望的候选者之一,因为它们在分割和非分配细胞中表现出高的转移效率,并且不会出现插入诱变的风险。然而,非整合慢病毒载体不能引入稳定的外源基因表达到分区细胞,从而限制其应用。在这里,我们报告了含有最小支架/基质附着区域(S / MAR)序列(SNIL)的非整合慢病毒载体的设计,并且该SNIL载体能够在分割细胞中保留异构体转基因表达。使用SNIL载体,我们在SNIL转导的稳定CHO细胞中检测到EGFP基因的表达61天,无论是选择还是不均。然而,在没有S / MAR序列的NIL组中,转导细胞在选择下死亡以进行氮载体的瞬时表达。此外,Southern印迹测定证明了SNIL载体在CHO细胞中保留了斑囊肿。总之,最小的S / MAR序列保留了分割细胞中的非整合慢病毒载体,这表明SNIL载体具有用作基因转移工具的可能性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号